Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ZenaTech’s ZenaDrone Interceptor P-1, Single-Use Autonomous Interceptor Drone, Targeted to Sell for Under $5,000 USD
-
LiveOne (Nasdaq: LVO) Announces B2B Partnership with Samsung TV; Expands Reach to 100M+ Smart TVs
-
Tejon Ranch Co. Announces Fourth Quarter and Year-Ended December 31, 2025 Financial Results
-
Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update
-
INmune Bio’s MINDFuL Trial Featured at AD/PD 2026 Plenary as Successful Example of How to Approach Clinical Trials Targeting Inflammation in Early Alzheimer’s Disease
-
Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update
-
Immutep Reports Progress from Phase I Study of LAG-3 Agonist for Autoimmune Diseases
-
Lincoln Educational Services Reviews Strategic Growth Initiatives and Long-Term Financial Targets During Investor Day; First Quarter 2026 Student Start Growth Expected to Rise 19%
-
Former ASOS CEO Nick Beighton Joins Kornit Digital to Help Shape the Future of On-Demand Fashion
-
PEDEVCO Reports Preliminary Fourth Quarter and Full Year 2025 Results Following Transformational Juniper Merger
-
Byrna Technologies Promotes Luan Pham to President
-
MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Livi
-
Aduro Signs MOU to Develop a Commercial Licence Package for Hydrochemolytic™ Technology
-
Holganix Announces the Launch of HGX, its Environmental Asset Division, to Reward Farmers’ Regenerative Agriculture Practices & Accelerate Corporate Sustainability Goals
-
Meltwater Named to G2’s 2026 Best Software Awards
-
PADO AI Announces $6 Million Seed Round to Deliver AI-Powered Workload Orchestration Resources for Data Centers to Maximize Compute per Megawatt™
-
Causeway Therapeutics Presents Data from Phase 2 Clinical Trial of TenoMiR® for Lateral Epicondylitis at RNA Leaders Europe 2026
-
Cargo Theft Firmly in the Cyber Era as Losses Exceed 6 Billion, Geotab Warns
-
InterAction Announces Next-Generation CRM Platform for Legal Professionals
-
Rhino.fi Launches Stablecoin 1:1 so Neobanks and Fintechs Can Settle Stablecoins Like Dollars
-
My Talking Tom Friends Adds a Second Floor; My Talking Tom 2 Expands Bathroom Gameplay
-
Forward Industries Announces Strategic Share Repurchase
-
Mobilicom’s Drone and Robotics Solutions Included in FCC’s First Batch of Trusted Drones as Determined by U.S. Department of War
-
Volatus Aerospace Announces Graduation to Toronto Stock Exchange; Trading to Commence March 20, 2026
-
NevGold Intercepts 11.42 g/t AuEq Over 7.7 Meters (2.64% Antimony And 1.17 g/t Au) Within 4.91 g/t AuEq Over 27.4 Meters (1.09% Antimony And 0.67 g/t Au); Initial Antimony-Gold Mineral Resource Estima
-
Myseum Granted U.S. Patent for Core Private and Encrypted Instant Social Networking and Media Technology
-
Knight Therapeutics Reports Fourth Quarter and Year-End 2025 Results
-
Development charge reform is needed to reduce housing costs and support new supply
-
Intuitive Machines Reports Fourth Quarter and Full-Year 2025 Financial Results
-
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant
-
NIOB Exploration Work Leads to Multiple Drill Targets
-
SL Green Refinances Corporate Credit Facility
-
Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide® May Reduce Leptomeningeal Metastases Healthcare Costs by 40%
-
Annovis Partners with NeuroRPM to Deploy AI-Powered Digital Biomarker Technology in Parkinson's Disease Study
-
BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental Health
-
Leading Independent Proxy Advisory Firm ISS Recommends Aptose Biosciences Shareholders Vote “FOR” Proposed Plan of Arrangement with Hanmi Pharmaceutical
-
TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital from Blue Owl and Expands Share Repurchase Program to $300 Million
-
NeuroRPM to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio's Parkinson's Disease Clinical Trial
-
Electra Provides Construction Progress Update on North America’s Only Cobalt Sulfate Refinery
-
InflaRx Reports Full Year 2025 Results and Highlights Key Achievements and Expected Milestones
-
Northern York County Regional Police Becomes First in State to Deploy WrapTactics LMS, Expands BolaWrap Non-Lethal Response Capabilities
-
Mount Logan Capital Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
-
KANZHUN LIMITED Announces Shareholder Return Target Through Dividend Distribution and Extension and Upsizing of Share Repurchase Program
-
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant
-
AlphaTON Capital Acquires Controlling Interest in GAMEE, Adding 119 Million Users to its Telegram Ecosystem Portfolio
-
CervoMed Announces New Data at the AD/PD™ 2026 Scientific Conference that Reinforce Neflamapimod’s Positive Effects in Dementia with Lewy Bodies (DLB) in Patients without Alzheimer’s Disease Co-
-
Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026
-
Biogen to Present New Late-Breaking Litifilimab Phase 2 AMETHYST Data in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting
-
NeuroRPM to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio's Parkinson's Disease Clinical Trial
-
Annovis Partners with NeuroRPM to Deploy AI-Powered Digital Biomarker Technology in Parkinson's Disease Study
